Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Japan, 1 March 2010 - Astellas Pharma Inc. (“Astellas”; Headquarters: Tokyo, President & CEO: Masafumi Nogimori) today announced that its subsidiary Astellas Pharma US, Inc. (Headquarters:...
Read more about Astellas to Send Additional Relief Effort following Haiti Earthquake
Japan, February 26, 2010 - Astellas Pharma Inc. (“Astellas” Headquarters: Chuo-ku, Tokyo; President & CEO: Masafumi Nogimori) announced today the withdrawal of the application for approval of...
Tokyo, Japan, February 24, 2010 - Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced today that it has entered into a license,...
Japan, January 19, 2010 - Astellas Pharma Inc. ("Astellas";Headquarters: Tokyo, President & CEO: Masafumi Nogimori) today announced that it will make a donation of 5 million yen to the Japanese...
Read more about Astellas to Support Relief Efforts following Haiti Earthquake
Tokyo, Japan, January 12, 2010 - Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) and AstraZeneca K.K. (headquarters: Tokyo; President and CEO:...
Read more about Launch of Symbicort® Turbuhaler®for the Treatment of Adult Bronchial Asthma in Japan
Japan, December 22, 2009 - Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced that it submitted an application for market authorization for...
Read more about Application for Orally Disintegrating Tablet YM905 in Japan
Follow us
